Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel
Journal cover image

Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.

Publication ,  Journal Article
Byrd, JC; Hertler, AA; Weiss, RB; Freiman, J; Kweder, SL; Diehl, LF
Published in: Ann Oncol
March 1995

Duke Scholars

Published In

Ann Oncol

DOI

ISSN

0923-7534

Publication Date

March 1995

Volume

6

Issue

3

Start / End Page

300 / 301

Location

England

Related Subject Headings

  • Vidarabine
  • Recurrence
  • Pentostatin
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Humans
  • Fatal Outcome
  • Autoimmune Diseases
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Byrd, J. C., Hertler, A. A., Weiss, R. B., Freiman, J., Kweder, S. L., & Diehl, L. F. (1995). Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. Ann Oncol, 6(3), 300–301. https://doi.org/10.1093/oxfordjournals.annonc.a059162
Byrd, J. C., A. A. Hertler, R. B. Weiss, J. Freiman, S. L. Kweder, and L. F. Diehl. “Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.Ann Oncol 6, no. 3 (March 1995): 300–301. https://doi.org/10.1093/oxfordjournals.annonc.a059162.
Byrd, J. C., et al. “Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia.Ann Oncol, vol. 6, no. 3, Mar. 1995, pp. 300–01. Pubmed, doi:10.1093/oxfordjournals.annonc.a059162.
Journal cover image

Published In

Ann Oncol

DOI

ISSN

0923-7534

Publication Date

March 1995

Volume

6

Issue

3

Start / End Page

300 / 301

Location

England

Related Subject Headings

  • Vidarabine
  • Recurrence
  • Pentostatin
  • Oncology & Carcinogenesis
  • Middle Aged
  • Male
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Humans
  • Fatal Outcome
  • Autoimmune Diseases